BioSpace News Archive

Fact.MR – A Market Research and Competitive Intelligence Provider: The global terminal sterilization market is expected to increase at a positive rate from 2021 to 2031.

Barbiturates act as central nervous system depressants. Barbiturates are derivatives of a chemical called barbituric acid.

A scar is an area of fibrous tissue that replaces normal skin after an injury. Scars form due to the biological process of wound repair in the skin and other organs and tissues of the body.

Rise in awareness about the antisocial personality disorder globally is anticipated to fuel the growth of the global antisocial personality disorder treatment market.

argenx, a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, announced that members of management will participate in a fireside chat at the 11th Annual SVB Leerink Global Healthcare Conference on Thursday, February 17, 2022 at 10:40 a.m. ET.

Vicore Pharma Holding AB, a clinical-stage pharmaceutical company developing medicines targeting the angiotensin II type 2 receptor, announces data from an interim analysis suggesting that C21 stabilizes disease and increases lung function in idiopathic pulmonary fibrosis patients as quantified by standard FVC measurement.

Vir Biotechnology, Inc. announced that preclinical data suggest that sotrovimab, an investigational monoclonal antibody authorized for emergency use in the United States and developed in conjunction with GlaxoSmithKline, retains neutralizing activity against the BA.2 subvariant of Omicron.

Swedish Orphan Biovitrum AB announces its results for the fourth quarter and full year of 2021.

Akeso, Inc. announced that the clinical trial application of the innovative nerve growth factor monoclonal antibody injection developed in-house by the Company, has obtained approval from the Centre for Drug Evaluation of China’s National Medical Products Administration to begin clinical trial for the treatment of pain.

Ixaka Ltd, an integrated cell and gene therapy company focused on the natural power of the body to cure disease, announces the appointment of Nick Robbins-Cherry as Chief Financial Officer and board Director, and George O’Rourke as Vice President and General Manager of Ixaka France.